Mitsubishi Tanabe Taking Control of Medicago for $357M
Québec City-based vaccine developer Medicago Inc. has agreed to be bought for $357 million by Japan's Mitsubishi Tanabe Pharma Corp. The company's board of directors unanimously approved the deal, which will next be considered at a shareholders meeting expected to occur before the end of August. Medicago has since the 1990's been backed by Canadian venture capital firms, including the Fonds de solidarité des travailleurs du Québec FTQ and Innovatech, and went public in 2006.
12 July 2013•7 mins read
